Nick Yoder

Company: Magenta Therapeutics

Job title: Direction, Bioconjugation

Seminars:

Design of MGTA-117, an Antibody-Drug Conjugate for Stem Cell Conditioning & Transplantation in Malignant Disease & Gene Therapy 9:40 am

Stem cell transplantation is a potentially curative therapy for life-threatening diseases, yet its use is limited by the need for “conditioning” recipients with intensive chemotherapy or radiation Hear about MGTA-117, an antibody-drug conjugate intended to condition patients by delivering an amanitin payload to CD117-expressing stem cells, while limiting systemic exposure Understand how MGTA-117 incorporates a…Read more

day: Day One